These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35001842)

  • 21. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: A randomized clinical trial in military veterans.
    Back SE; Killeen T; Badour CL; Flanagan JC; Allan NP; Ana ES; Lozano B; Korte KJ; Foa EB; Brady KT
    Addict Behav; 2019 Mar; 90():369-377. PubMed ID: 30529244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Depression Suppresses Treatment Response for Traumatic Loss-Related Posttraumatic Stress Disorder in Active Duty Military Personnel.
    Jacoby VM; Hale W; Dillon K; Dondanville KA; Wachen JS; Yarvis JS; Litz BT; Mintz J; Young-McCaughan S; Peterson AL; Resick PA;
    J Trauma Stress; 2019 Oct; 32(5):774-783. PubMed ID: 31461575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of exposure-based cognitive behaviour therapy for post-traumatic stress disorder in emergency service personnel: a randomised clinical trial.
    Bryant RA; Kenny L; Rawson N; Cahill C; Joscelyne A; Garber B; Tockar J; Dawson K; Nickerson A
    Psychol Med; 2019 Jul; 49(9):1565-1573. PubMed ID: 30149825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of prolonged exposure on sleep and enhancing treatment outcomes with evidence-based sleep interventions: A pilot study.
    Walters EM; Jenkins MM; Nappi CM; Clark J; Lies J; Norman SB; Drummond SPA
    Psychol Trauma; 2020 Feb; 12(2):175-185. PubMed ID: 31246050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychotherapy for Military-Related PTSD: A Review of Randomized Clinical Trials.
    Steenkamp MM; Litz BT; Hoge CW; Marmar CR
    JAMA; 2015 Aug; 314(5):489-500. PubMed ID: 26241600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in physiological reactivity in response to the trauma memory during prolonged exposure and virtual reality exposure therapy for posttraumatic stress disorder.
    Katz AC; Norr AM; Buck B; Fantelli E; Edwards-Stewart A; Koenen-Woods P; Zetocha K; Smolenski DJ; Holloway K; Rothbaum BO; Difede J; Rizzo A; Skopp N; Mishkind M; Gahm G; Reger GM; Andrasik F
    Psychol Trauma; 2020 Oct; 12(7):756-764. PubMed ID: 32338946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Posttraumatic Stress Disorder in U.S. Military Primary Care: Trajectories and Predictors of One-Year Prognosis.
    Bray RM; Engel CC; Williams J; Jaycox LH; Lane ME; Morgan JK; Unützer J
    J Trauma Stress; 2016 Aug; 29(4):340-8. PubMed ID: 27447948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benchmarking secondary outcomes to posttraumatic stress disorder symptom change in response to cognitive processing and written exposure therapy for posttraumatic stress disorder.
    Stoycos SA; Straud CL; Stanley IH; Marx BP; Resick PA; Young-McCaughan S; Peterson AL; Sloan DM;
    J Anxiety Disord; 2023 Dec; 100():102794. PubMed ID: 37980801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Randomized, Head-to-Head Study of Virtual Reality Exposure Therapy for Posttraumatic Stress Disorder.
    McLay RN; Baird A; Webb-Murphy J; Deal W; Tran L; Anson H; Klam W; Johnston S
    Cyberpsychol Behav Soc Netw; 2017 Apr; 20(4):218-224. PubMed ID: 28394217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comorbid Posttraumatic Stress Disorder and Traumatic Brain Injury: Generalization of Prolonged-Exposure PTSD Treatment Outcomes to Postconcussive Symptoms, Cognition, and Self-Efficacy in Veterans and Active Duty Service Members.
    Wolf GK; Mauntel GJ; Kretzmer T; Crawford E; Thors C; Strom TQ; Vanderploeg RD
    J Head Trauma Rehabil; 2018; 33(2):E53-E63. PubMed ID: 28926486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The efficacy of a single imaginal exposure-writing assignment in reducing posttraumatic stress and depressive symptoms: A pilot study.
    Vinke YD; Truijens F; van Polanen Petel E; van Emmerik AAP
    J Clin Psychol; 2019 Sep; 75(9):1519-1526. PubMed ID: 31141176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancing Extinction Learning in Posttraumatic Stress Disorder With Brief Daily Imaginal Exposure and Methylene Blue: A Randomized Controlled Trial.
    Zoellner LA; Telch M; Foa EB; Farach FJ; McLean CP; Gallop R; Bluett EJ; Cobb A; Gonzalez-Lima F
    J Clin Psychiatry; 2017 Jul; 78(7):e782-e789. PubMed ID: 28686823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of prolonged exposure and virtual reality exposure on suicidal ideation in active duty soldiers: An examination of potential mechanisms.
    Norr AM; Smolenski DJ; Reger GM
    J Psychiatr Res; 2018 Aug; 103():69-74. PubMed ID: 29783077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized, controlled trial of virtual reality-graded exposure therapy for post-traumatic stress disorder in active duty service members with combat-related post-traumatic stress disorder.
    McLay RN; Wood DP; Webb-Murphy JA; Spira JL; Wiederhold MD; Pyne JM; Wiederhold BK
    Cyberpsychol Behav Soc Netw; 2011 Apr; 14(4):223-9. PubMed ID: 21332375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrated Treatment of PTSD and Substance Use Disorders: Examination of Imaginal Exposure Length.
    Mills AC; Badour CL; Korte KJ; Killeen TK; Henschel AV; Back SE
    J Trauma Stress; 2017 Apr; 30(2):166-172. PubMed ID: 28329434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancing exposure therapy for posttraumatic stress disorder (PTSD): a randomized clinical trial of virtual reality and imaginal exposure with a cognitive enhancer.
    Difede J; Rothbaum BO; Rizzo AA; Wyka K; Spielman L; Reist C; Roy MJ; Jovanovic T; Norrholm SD; Cukor J; Olden M; Glatt CE; Lee FS
    Transl Psychiatry; 2022 Jul; 12(1):299. PubMed ID: 35896533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Massed versus standard prolonged exposure for posttraumatic stress disorder in Australian military and veteran populations (RESTORE trial): Study protocol for a non-inferiority randomized controlled trial.
    Dell L; Sbisa AM; O'Donnell M; Tuerk PW; Bryant R; Hodson S; Morton D; Battersby M; Forbes A; Forbes D
    Contemp Clin Trials; 2021 Aug; 107():106478. PubMed ID: 34119717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of Fibromyalgia Syndrome in Active-Duty Military Personnel.
    Lawrence-Wolff KM; Higgs JB; Young-McCaughan S; Mintz J; Foa EB; Resick PA; Kelly KM; Maurer DM; Borah AM; Yarvis JS; Litz BT; Hildebrand BA; Williamson DE; Peterson AL;
    Arthritis Care Res (Hoboken); 2023 Mar; 75(3):667-673. PubMed ID: 34606694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longitudinal Associations among Posttraumatic Stress Disorder Symptoms, Traumatic Brain Injury, and Neurocognitive Functioning in Army Soldiers Deployed to the Iraq War.
    Vasterling JJ; Aslan M; Lee LO; Proctor SP; Ko J; Jacob S; Concato J
    J Int Neuropsychol Soc; 2018 Apr; 24(4):311-323. PubMed ID: 29199924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deployed Military Medical Personnel: Impact of Combat and Healthcare Trauma Exposure.
    Peterson AL; Baker MT; Moore CBA; Hale WJ; Joseph JS; Straud CL; Lancaster CL; McNally RJ; Isler WC; Litz BT; Mintz J
    Mil Med; 2019 Jan; 184(1-2):e133-e142. PubMed ID: 29931192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.